⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 21, 2025PharmaceuticalsOpen Access

Correction: Onodera et al. Prognostic Factors and Talaporfin Sodium Concentration in Photodynamic Therapy for Recurrent Grade 4 Glioma. Pharmaceuticals 2025, 18, 583

Mikoto Onodera Shuji Kitahara Yasuto Sato Takakazu Kawamata Yoshihiro Muragaki Ken Masamune

View Full Paper

Ask AI

Bookmark

Share

Key Points

Prognostic factors influence treatment outcomes in patients with recurrent grade 4 glioma.
Findings indicate a strong correlation with talaporfin sodium concentration.
Assessment through observational analysis on the impact of photodynamic therapy.
These insights may enable better therapeutic approaches for a challenging brain tumor.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Analysis reveals significant prognostic factors in photodynamic therapy for recurrent grade 4 glioma, suggesting improved treatment outcomes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Onodera et al. (2025) studied this question.

synapsesocial.com/papers/68fa1210f9f8b44535bfccae https://doi.org/10.3390/ph18101586

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1CNSC-01. PROGNOSTIC FACTORS AND TALAPORFIN SODIUM CONCENTRATION IN PHOTODYNAMIC THERAPY FOR RECURRENT GRADE 4 GLIOMA2025
2Abstract 7593: Photodynamic therapy improves therapeutic management of glioblastoma2024 · 1 citations
3Molecular Insights into Photodynamic Therapy of Glioma2024
4Photodynamic therapy using talaporfin sodium and semiconductor laser induces dose and time dependent cytocidal effect for human glioma derived stem cells2025
5Photodynamic therapy using talaporfin sodium for grade 2/3 meningiomas: a preliminary study of safety, feasibility, and clinical outcomesFeasibility Study · 2026

More related papers

Abstract A017: Cell-specific photodynamic therapy for high grade gliomas2024
Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240)2024
P1.128. Talaporfin Sodium Photodynamic Therapy for Locally Recurrent Esophageal Squamous Cell Carcinoma After Chemoradiotherapy2026

More from Pharmaceuticals

Quality of Life in Patients with Treatment-Resistant Depression Treated with Intranasal Esketamine as Add-On Therapy to an SSRI—A Prospective, Comparative Study in Real-World Clinical PracticeMon,
Multi-Omics Analysis Identifies Gut-Associated Metabolic Signatures Associated with Metformin-Mediated Protection Against LPS-Induced Lung InjurySun,